Extract Ameliorates LPS-Induced Septic Shock in Mice.

Evid Based Complement Alternat Med

College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.

Published: May 2022

Objective: has been reported for its anti-inflammatory properties. However, its efficacy in sepsis has yet to be reported. In this study, we studied the ability of extract (DIE) to rescue mice from septic shock and sepsis.

Methods: studies included the measurement of secreted nitric oxide, cell viability, gene and protein expression via real-time polymerase chain reaction and western blot, and confocal microscopy in RAW 264.7 cells. studies include a model of septic shock and sepsis in BALB/c mice induced by a lethal and sub-lethal dose of lipopolysaccharide (LPS).

Results: DIE suppressed the expression of proinflammatory cytokines induced by LPS and prevented the translocation of NFB into the nucleus of RAW 264.7 cells. It also prevented reactive oxygen species damage induced by LPS in murine bone marrow-derived macrophages. Models of sepsis and septic shock were established in BALB/ mice and DIE-rescued mice from septic shock. DIE also reversed the increase in tumor necrosis factor- and nitrite levels in the serum of mice induced with sepsis. DIE also prevented the translocation of NFB from the cytosol into the nucleus in murine lungs. Histopathological damage induced by sepsis was reversed in the testis, liver, and lungs of mice.

Conclusion: In conclusion, DIE is a suitable candidate for development as a therapeutic agent for sepsis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124116PMC
http://dx.doi.org/10.1155/2022/5783867DOI Listing

Publication Analysis

Top Keywords

septic shock
20
mice septic
8
raw 2647
8
2647 cells
8
mice induced
8
induced lps
8
prevented translocation
8
translocation nfb
8
damage induced
8
induced sepsis
8

Similar Publications

Background: High levels of catecholamines are cardiotoxic and associated with stress-induced cardiomyopathies. Septic patients are routinely exposed to endogenously released and exogenously administered catecholamines, which may alter cardiac function and perfusion causing ischemia. Early during human septic shock, left ventricular ejection fraction (LVEF) decreases but normalizes in survivors over 7-10 days.

View Article and Find Full Text PDF

Malaria is highly prevalent in West and Central Africa. In the United States, most reported cases are due to immigration from endemic regions. Severe malaria caused by Plasmodium ovale is rare.

View Article and Find Full Text PDF

Patients with selective IgA deficiency could have various clinical presentations ranging from asymptomatic to severe respiratory or gastrointestinal tract infection, as well as autoimmune disease and allergic reactions. Selective IgA deficiency is relatively common in Caucasians, but it is rare in the Asian population, meaning it could be easily missed in the clinic. In this study, we report a 26-year-old man with a history of asthma and nephrotic syndrome.

View Article and Find Full Text PDF

In Light of the LANDI-SEP Trial: New Evidence or Double Jeopardy?

Indian J Crit Care Med

January 2025

Department of Critical Care Medicine, Ruby Hall Hospital, Pune, Maharashtra, India.

Datta PK, Sathe P, Bhattacharjee A, Kundu R. In Light of the LANDI-SEP Trial: New Evidence or Double Jeopardy? Indian J Crit Care Med 2025;29(1):84-85.

View Article and Find Full Text PDF

Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA Adverse Event Reporting database.

Ther Adv Drug Saf

January 2025

Department of Pharmacy, Daping Hospital, Army Medical University, No. 10 Changjiang Branch Road, Yuzhong District, Chongqing 400042, China.

Background: Gilteritinib and midostaurin are FLT3 inhibitors that have made significant progress in the treatment of acute myeloid leukemia. However, their real-world safety profile in a large sample population is incomplete.

Objectives: We aimed to provide a pharmacovigilance study of the adverse events (AEs) associated with gilteritinib and midostaurin through the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!